← Back to AARD Overview
Aardvark Therapeutics, Inc. Common Stock (AARD)
Earnings & Profitability History
Latest EPS
$-0.81
Net Income
-17598000
Financial Fundamentals
AARD • Quarterly Data • 5Y View
Historical Data Table
Quarterly Net Income & EPS
| Date | Net Income ($B) | NI YoY % | TTM NI | EPS | EPS YoY % | TTM EPS |
|---|---|---|---|---|---|---|
| 2025-12-31 | -0.02 | -100.5% | -0.06 | -0.81 | -19.1% | -2.93 |
| 2025-09-30 | -0.02 | -290.1% | -0.05 | -0.75 | -134.4% | -2.80 |
| 2025-06-30 | -0.01 | -163.7% | -0.04 | -0.66 | +69.0% | -2.37 |
| 2025-03-31 | -0.01 | -327.5% | -0.03 | -0.71 | -317.6% | -3.84 |
| 2024-12-31 | -0.01 | -330.1% | -0.02 | -0.68 | -223.8% | -3.30 |
| 2024-09-30 | -0.00 | -98.3% | -0.01 | -0.32 | -45.5% | -2.83 |
| 2024-06-30 | -0.01 | — | -0.01 | -2.13 | — | -2.73 |
| 2024-03-31 | -0.00 | — | — | -0.17 | — | — |
| 2023-12-31 | -0.00 | — | — | -0.21 | — | — |
| 2023-09-30 | -0.00 | — | — | -0.22 | — | — |
Annual Performance
| Year | Net Income ($B) | Growth % | EPS | EPS Growth % |
|---|---|---|---|---|
| 2025 | -0.06 | -179.7% | -2.93 | -84.3% |
| 2024 | -0.02 | -185.6% | -1.59 | -183.9% |
| 2023 | -0.01 | +46.9% | -0.56 | +59.7% |
| 2022 | -0.01 | — | -1.39 | — |